Study of Prophylaxis, ACtivity and Effectiveness (SPACE) in Hemophilia Patients Currently Treated With ADVATE or RIXUBIS
Clinical trial NCT02190149 · COMPLETED
Trial details
- NCT number
- NCT02190149
- Sponsor
- Baxalta now part of Shire
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2014-07-22
- Primary completion
- 2016-03-29
- Enrollment
- 64
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.